Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients

Cut A Andra, Aldy S Rambe, Refli Hasan, Rosita Sembiring, Doni Firman, Putri C Eyanoer, Zulfikri Mukhtar, Taufik Sungkar, Muhammad Rusda, Mustafa M Amin · 2023

Read Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients by Cut A Andra, Aldy S Rambe, Refli Hasan, Rosita Sembiring, Doni Firman, Putri C Eyanoer, Zulfikri Mukhtar, Taufik Sungkar, Muhammad Rusda, Mustafa M Amin (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10919436.txt.

Description

Coronary artery disease (CAD) remains a significant global health concern with considerable high morbidity and mortality and its development is influenced by various genetic and environmental factors. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a vital regulator of low-density lipoprotein receptor (LDLR) metabolism, directly impacting serum cholesterol levels. However, its role in development of CAD is not fully understood.

Catalog record

CREATORCut A Andra, Aldy S Rambe, Refli Hasan, Rosita Sembiring, Doni Firman, Putri C Eyanoer, Zulfikri Mukhtar, Taufik Sungkar, Muhammad Rusda, Mustafa M Amin
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10919436

Browse the full library · About the Tower of Babel